2017-06-11 Frontiers in Neurophotonics Summer School

The Frontiers in Neurophotonics Summer School is an opportunity to meet fellow researchers and students from around the world, discuss and discover the latest advances in live cell optical imaging techniques put in perspective by experimental challenges in the field of neuroscience.

Frontiers in Neurophotonics is aimed at MSc. PhD, and junior post-doctoral fellows.

The school will combine tutorials given by experts in photonics and neuroscience and hands-on experiments involving advanced optical approaches to measure, manipulate and follow molecular events in living neuronal cells.


  • David Boas – Boston University, USA
  • Daniel Côté – Université Laval, Canada
  • Paul DeKoninck – Université Laval, Canada
  • Yves DeKoninck Université Laval, Canada
  • Stéphane Dieudonné – École Normale Supérieure, Paris, France
  • Kurt Haas – University of British Columbia, Canada
  • Thomas Kuner – University of Heidelberg, Germany
  • Pierre Marquet – Université Laval, Canada
  • Tim Murphy – University of British Columbia, Canada
  • Ed Ruthazer – McGill University, Canada
  • Jean-Baptiste Sibarita, Université de Bordeaux, France
  • …and more to come!


  • Tracking cell migration and maturation in live brain slices. Example
  • Video-rate multimodal imaging in vivo. Example
  • Coherent Anti-stokes Raman Scattering microscopy. Example
  • Imaging protein trafficking in various neuronal compartments. Example
  • Tracking of single receptors on membrane Example
  • Fluorescence lifetime approaches. Example
  • Photobleaching and Photoactivation techniques. Example
  • Two-photon calcium imaging in axons and dendrites
  • Mapping synaptic connections between neurons
  • Super-resolution optical imaging
  • Optical microprobe applications in vivo

The school is supported with funds from Brain Canada. We hope to see you in Quebec !

2017-05-24 8th international symposium of the Society for Research on the Cerebellum and Ataxias

Winnipeg, Manitoba, May 24 – 26 2017

Theme: Cerebellum: from Development to Disease

The Society for Research on the Cerebellum and Ataxia (SRCA) is an international professional society of scientists interested in research on the cerebellum and its associated disorders. In recent years, there has been tremendous growth in research on cerebellar motor and non-motor functions, and the cerebellum has been shown to play a critical role in diverse diseases including ataxias, autism spectrum disorder and cognitive impairment. Basic and clinical research will be highlighted at the 8th Annual SRCA Symposium in Winnipeg, providing unparalleled opportunities for networking and presentation of leading-edge research results.

More details on the Society for Research on the Cerebellum and Ataxias website

2017-05-08 39th International Symposium of the Groupe de recherche sur le système nerveux central (GRSNC) “Dementia and cognition: A vascular perspective”

The 39th International Symposium of the Groupe de recherche sur le système nerveux central (GRSNC), entitled “Dementia and cognition: A vascular perspective”, will be held on May 8-9, 2017 at Université de Montréal. This symposium is organized by Dr. Patrice Brassard, Dr. Claudine Gauthier, Dr. Hélène Girouard, Dr. Florencia Iulita and Dr. Lisa Marie Munter.

Research on dementia and cognition has experienced a rapid growth in the last 20 years. It addresses a great diversity of questions and scientific approaches, ranging from animals to humans. In this symposium, we will discuss cutting-edge research on dementia and cognition from a vascular point of view, reviewing the progress that has been made and addressing the central open questions facing this rapidly developing field. In planning the sessions, we have paid particular attention to issues that stretch from the most basic neuroscience all the way to clinical applications. We will highlight converging evidence from the full range of neuroscientific methods applied in this field, considered within a diversity of conceptual frameworks. There will be four sessions of presentations by invited speakers from around the world as well as two contributed poster sessions.

The presentations are divided in four sessions:

  1. Biomarkers and vascular risk factors in dementia
  2. Cerebrovascular functions and dementia: Back to basics
  3. The continuum from stroke to Alzheimer’s disease
  4. Prevention, rehabilitation and treatment of vascular dementia

Registration deadline: Thursday, May 4th 2017

Abstract submission deadline: Thursday, March 31st 2017

Symposium venue: Room B-2245, Pavillon 3200 Jean-Brillant, Université de Montréal

More information on the meeting website:

2017-03-04 37th European Winter Conference on Brain Research (EWCBR)

The EWCBR Organizing Committee has the pleasure to inform you that our Conference 2017 will take place in ARC 1800, FRANCE.
The Golf Hotel, built by Le Corbusier, is right on the slopes of the legendary Les Arcs resort, with stunning views of the mountains. Outdoor swimming-pool and SPA.
The Scientific Committee, as in previous years, invites participants to organize scientific sessions on a particular theme of their interest.
We anticipate that the program be as wide as possible, from molecular neurobiology to clinical neurology, including electrophysiology, pharmacology, physiology, cognition, anatomy, pathology, behaviour, genetics, functional imagery, etc. the underlying priority of this
conference being “interdisciplinary communication”.
View more information on the event advertisement PDF: ewcbr-nov-2016

2017-02-24 Non-Invasive Delivery of Macromolecules Conference 2017

Non-Invasive Delivery of Macromolecules Conference 2017
21st – 24th February 2017 – Rancho Bernardo Inn, San Diego, CA

Scientific progress over the last three decades has resulted in a multitude of macromolecular biologic therapeutics – mostly proteins and peptides. Effective and efficient delivery of these biopharmaceuticals has been limited to traditional injections. Administration of these biopharmaceuticals using a variety of novel minimally invasive approaches would offer not only the potential for increased patient compliance but also improved safety/efficacy in certain instances. Many common issues must be addressed to successfully develop various strategies being explored for macromolecule delivery via the oral, transdermal, nasal, pulmonary, and ocular routes of administration as well as across the blood-brain barrier. A new interdisciplinary meeting has now been organized to bring together experts from the various fields of biology, chemistry, material science, engineering, and drug delivery. The goal of this meeting is to provide an open and creative forum for academic and industrial scientists to discuss the spectrum of activities (from concept to clinical testing) required for successful development of clinical products.
Visit the conference website for more information:
For more information, contact Isabelle Aubert at